These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 22400902

  • 1. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
    Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H, Wang J, Yuan YC, Frankel P, Li S, Ashing-Giwa KT, Sun G, Wang Y, Smith R, Robinson K, Ren X, Wang SE.
    J Transl Med; 2012 Mar 08; 10():42. PubMed ID: 22400902
    [Abstract] [Full Text] [Related]

  • 2. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 3. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 10; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 4. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012 Jul 10; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 5. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
    Zhu W, Liu M, Fan Y, Ma F, Xu N, Xu B.
    Cancer Med; 2018 Sep 10; 7(9):4420-4433. PubMed ID: 30099860
    [Abstract] [Full Text] [Related]

  • 6. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
    Liu B, Su F, Chen M, Li Y, Qi X, Xiao J, Li X, Liu X, Liang W, Zhang Y, Zhang J.
    Hum Pathol; 2017 Jun 10; 64():44-52. PubMed ID: 28412211
    [Abstract] [Full Text] [Related]

  • 7. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
    Madhavan D, Peng C, Wallwiener M, Zucknick M, Nees J, Schott S, Rudolph A, Riethdorf S, Trumpp A, Pantel K, Sohn C, Chang-Claude J, Schneeweiss A, Burwinkel B.
    Carcinogenesis; 2016 May 10; 37(5):461-70. PubMed ID: 26785733
    [Abstract] [Full Text] [Related]

  • 8. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, Graham K, Mackey JR, Kovalchuk O, Damaraju S.
    BMC Genomics; 2015 Sep 29; 16():735. PubMed ID: 26416693
    [Abstract] [Full Text] [Related]

  • 9. Next-generation sequencing of microRNAs for breast cancer detection.
    Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q.
    J Biomed Biotechnol; 2011 Sep 29; 2011():597145. PubMed ID: 21716661
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
    Marino AL, Evangelista AF, Vieira RA, Macedo T, Kerr LM, Abrahão-Machado LF, Longatto-Filho A, Silveira HC, Marques MM.
    BMC Cancer; 2014 Oct 02; 14():739. PubMed ID: 25277099
    [Abstract] [Full Text] [Related]

  • 11. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching PA, Fehm T, Schneeweiss A, Beck T, Lorenz R, Friedl TWP, Janni W, Rack B, SUCCESS Study Group.
    BMC Cancer; 2018 Feb 06; 18(1):141. PubMed ID: 29409452
    [Abstract] [Full Text] [Related]

  • 12. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
    Hafez MM, Hassan ZK, Zekri AR, Gaber AA, Al Rejaie SS, Sayed-Ahmed MM, Al Shabanah O.
    Asian Pac J Cancer Prev; 2012 Feb 06; 13(2):591-8. PubMed ID: 22524830
    [Abstract] [Full Text] [Related]

  • 13. Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.
    Kelly H, Downing T, Tuite NL, Smith TJ, Kerin MJ, Dwyer RM, Clancy E, Barry T, Reddington K.
    PLoS One; 2015 Feb 06; 10(9):e0137389. PubMed ID: 26355751
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H, Lobo J, Salta S, Amorim M, Lopes P, Cantante M, Reis B, Antunes L, Castro F, Palma de Sousa S, Gonçalves CS, Costa BM, Henrique R, Jerónimo C.
    J Transl Med; 2019 Dec 30; 17(1):435. PubMed ID: 31888645
    [Abstract] [Full Text] [Related]

  • 15. miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments.
    Martinez-Gutierrez AD, Catalan OM, Vázquez-Romo R, Porras Reyes FI, Alvarado-Miranda A, Lara Medina F, Bargallo-Rocha JE, Orozco Moreno LT, Cantú De León D, Herrera LA, López-Camarillo C, Pérez-Plasencia C, Campos-Parra AD.
    Int J Mol Med; 2019 Oct 30; 44(4):1267-1280. PubMed ID: 31364724
    [Abstract] [Full Text] [Related]

  • 16. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 17. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
    Ozawa PMM, Vieira E, Lemos DS, Souza ILM, Zanata SM, Pankievicz VC, Tuleski TR, Souza EM, Wowk PF, Urban CA, Kuroda F, Lima RS, Almeida RC, Gradia DF, Cavalli IJ, Cavalli LR, Malheiros D, Ribeiro EMSF.
    Biomolecules; 2020 Jan 16; 10(1):. PubMed ID: 31963351
    [Abstract] [Full Text] [Related]

  • 18. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV, Loginov VI, Burdennyy AM, Fridman MV, Senchenko VN, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA.
    Gene; 2017 Mar 10; 604():1-8. PubMed ID: 27998789
    [Abstract] [Full Text] [Related]

  • 19. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
    McDermott AM, Kerin MJ, Miller N.
    PLoS One; 2013 Mar 10; 8(12):e83718. PubMed ID: 24391813
    [Abstract] [Full Text] [Related]

  • 20. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A, Intabli H, Alkhayal W, Eltabache C, Tweigieri T, Amer SB.
    BMC Cancer; 2017 Nov 28; 17(1):799. PubMed ID: 29183284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.